StemCells
-
Financial
StemCells CEO, CFO and three directors resigned the day of merger that boosted stock sevenfold
By: TOMI KILGORE/EMMA COURT – August 17, 2016 The day that StemCells Inc. entered a merger that sent its stock rocketing up…
Read More » -
Financial
StemCells terminates mid-stage study; to wind down ops
Tue May 31, 2016 – Reporting by Amrutha Penumudi in Bengaluru StemCells Inc said on Tuesday it had terminated a mid-stage trial…
Read More » -
Neuro
Court Rules That StemCells, Inc. Lacks Standing to Pursue Patent Infringement Suit
NEWARK, Calif., July 23, 2015 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the…
Read More » -
Spine
StemCells, Inc. Completes Enrollment of First Cohort in Phase II Pathway Study for Cervical Spinal Cord Injury
NEWARK, Calif., Apr 16, 2015 (GLOBE NEWSWIRE via COMTEX) — StemCells, Inc. STEM, +1.59% a leading stem cell company developing…
Read More »